The scientists identified several, including the investigational
cancer drug BEZ235, which blocked a key metabolic pathway in flu -
infected human
lung epithelial
cells.
In a letter published in the
cancer journal Annals of Oncology, researchers led by Professor Jean - Philippe Spano, head of the medical oncology department at Pitie - Salpetriere Hospital AP - HP in Paris, France, report that while treating an HIV -
infected lung cancer patient with the
cancer drug nivolumab, they observed a «drastic and persistent decrease» in the reservoirs of
cells in the body where the human immunodeficiency virus (HIV) is able to hide away from attack by anti-retroviral therapy.